These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12630973)

  • 1. Pharmacokinetics of vanadium in humans after intravenous administration of a vanadium containing albumin solution.
    Heinemann G; Fichtl B; Vogt W
    Br J Clin Pharmacol; 2003 Mar; 55(3):241-5. PubMed ID: 12630973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vanadium-contaminated perioperatively administered infusion solutions and drugs.
    Heinemann G; Vogt W
    Biol Trace Elem Res; 2000; 75(1-3):227-34. PubMed ID: 11051612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects.
    Retlich S; Duval V; Ring A; Staab A; Hüttner S; Jungnik A; Jaehde U; Dugi KA; Graefe-Mody U
    Clin Pharmacokinet; 2010 Dec; 49(12):829-40. PubMed ID: 21053992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of vanadium-contaminated commercially available albumin solutions on renal tubular function.
    Heinemann G; Braun S; Overbeck M; Page M; Michel J; Vogt W
    Clin Nephrol; 2000 Jun; 53(6):473-8. PubMed ID: 10879668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles.
    Kuhnz W; Staks T; Jütting G
    Contraception; 1993 Dec; 48(6):557-75. PubMed ID: 8131397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man. A study using a stable isotope techique.
    Heikkinen H; Saraheimo M; Antila S; Ottoila P; Pentikäinen PJ
    Eur J Clin Pharmacol; 2001; 56(11):821-6. PubMed ID: 11294372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanadium pharmacokinetics and oral bioavailability upon single-dose administration of vanadyl sulfate to rats.
    Azay J; Brès J; Krosniak M; Teissedre PL; Cabanis JC; Serrano JJ; Cros G
    Fundam Clin Pharmacol; 2001 Oct; 15(5):313-24. PubMed ID: 11903500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W; Staks T; Jütting G
    Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W; Baumann A; Staks T; Dibbelt L; Knuppen R; Jütting G
    Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved determination of vanadium in biological fluids by electrothermal atomic absorption spectrometry.
    Ishida O; Kihira K; Tsukamoto Y; Marumo F
    Clin Chem; 1989 Jan; 35(1):127-30. PubMed ID: 2910551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of vandetanib: three phase I studies in healthy subjects.
    Martin P; Oliver S; Kennedy SJ; Partridge E; Hutchison M; Clarke D; Giles P
    Clin Ther; 2012 Jan; 34(1):221-37. PubMed ID: 22206795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Storage and elimination of titanium, aluminum, and vanadium salts, in vivo.
    Merritt K; Margevicius RW; Brown SA
    J Biomed Mater Res; 1992 Nov; 26(11):1503-15. PubMed ID: 1447232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers.
    Ericsson H; Fakt C; Jolin-Mellgård A; Nordlander M; Sohtell L; Sunzel M; Regårdh CG
    Br J Clin Pharmacol; 1999 May; 47(5):531-8. PubMed ID: 10336577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study.
    Xu Z; Bouman-Thio E; Comisar C; Frederick B; Van Hartingsveldt B; Marini JC; Davis HM; Zhou H
    Br J Clin Pharmacol; 2011 Aug; 72(2):270-81. PubMed ID: 21392075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and safety of 6 % hydroxyethyl starch 130/0.4 in healthy male volunteers of Japanese ethnicity after single infusion of 500 ml solution.
    Yamakage M; Bepperling F; Wargenau M; Miyao H
    J Anesth; 2012 Dec; 26(6):851-7. PubMed ID: 22729229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers.
    Ericsson H; Bredberg U; Eriksson U; Jolin-Mellgård A; Nordlander M; Regårdh CG
    Anesthesiology; 2000 Apr; 92(4):993-1001. PubMed ID: 10754618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers.
    Danielson BG; Salmonson T; Derendorf H; Geisser P
    Arzneimittelforschung; 1996 Jun; 46(6):615-21. PubMed ID: 8767353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials.
    Chabot GG; Abigerges D; Catimel G; Culine S; de Forni M; Extra JM; Mahjoubi M; Hérait P; Armand JP; Bugat R
    Ann Oncol; 1995 Feb; 6(2):141-51. PubMed ID: 7786822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.